SPXA SpectrumDNA, Inc. featured news, full reports, and detailed charts
SpectrumDNA, Inc. (SPXA/SPXA.OB) Wrap Up:
SpectrumDNA, Inc., through its subsidiary, SpectrumDNA Studios, Inc., develops consumer and business digital networked applications for the Web and mobile wireless. Its applications are referred as Web 2.0 applications, Web engines, networked engines, and enginets. SpectrumDNA’s enginets are networked applications delivered through networked media that are designed to engage a target audience around a particular human behavior, such as dating, creating, sharing of content, social networking, ecommerce, and trading. The company was incorporated in 2006 and is based in Park City, Utah.SpectrumDNA, Inc. (SPXA:OTC Bulletin Board Market)
Snapshot of SpectrumDNA, Inc. (SPXA)
|
OPEN
--
|
PREVIOUS CLOSE
$0.14
|
|
|
DAY HIGH
--
|
DAY LOW
--
|
|
|
52 WEEK HIGH
05/18/09 - $0.45
|
52 WEEK LOW
02/24/09 - $0.08
|
|
|
MARKET CAP
6.8M
|
AVERAGE VOLUME 3 mo
7.7K
|
|
|
DILUTED EPS TTM
--
|
SHARES OUTSTANDING
48.7M
|
|
|
SPXA Does Not Pay Dividends
|
P/E TTM
NM
|
|
| K = Thousands M = Millions B = Billions | ||
SPXA Top Compensated Officers
Executives, Board Directors
Key developments for SpectrumDNA, Inc. (SPXA)
SpectrumDNA Inc. has signed a contract with the New York Post to license its Addictionary, a SaaS (software-as-a-service) user-generated dictionary that lets people create their own words and definitions. Known for its eye-catching headlines, ground-breaking gossip and play on words, the New York Post reaches nearly 5.5 million online unique users per month and is a natural fit for the Addictionary social media application. The New York Addictionary will serve as an engine to increase key metrics of user engagement including page views, time spent on site, frequency of visits, viral and word-of-mouth distribution and premium ad and sponsorship inventory. The application is set to launch in August and will pave the way for derivative products such as greeting cards, calendars, games and books featuring the top-rated words created by the community at nypost.com. The New York Post Addictionary joins a network of social media communities which includes NBC's 'The Office' Addictionary, E! Entertainment's Celebrity Addictionary, Comedy Central's Political Addictionary, Dictionary.com's Addictionary and FEARnet's Horror Addictionary.
SpectrumDNA Inc. announced the appointment of Jeff Nolan, entrepreneur, venture capitalist and prolific social media strategist, to its board of directors. Most recently, Mr. Nolan was the VP Corporate Development at NewsGator Technologies.
SpectrumDNA Inc. announced the appointment of Jeff Nolan, entrepreneur, venture capitalist and prolific social media strategist, to its board of directors. Most recently, Mr. Nolan was the VP Corporate Development at NewsGator Technologies. During his tenure, Mr. Nolan oversaw restructuring of NewsGator into enterprise software and media business units operating independently of each other. He also worked to establish brand leadership for the company in the widget and content syndication market space. Mr. Nolan brings to the SpectrumDNA board an extensive background in technology and Internet infrastructure and also deep marketing skills.
SPXA Competitors
| Company | Last | Change |
| Google Inc | $569.96 USD | -3.03 |
| Internet Capital Group Inc | $6.64 USD | +0.02 |
| Microsoft Corp | $29.62 USD | -0.16 |
| News Corp | $11.98 USD | -0.46 |
| Yahoo! Inc | $15.38 USD | -0.23 |
| Market data is delayed at least 20 minutes. | ||
Industry Analysis
| Valuation | SPXA | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 57.3x |
|
| Price/Book | 51.8x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 56.3x |
|
|
SPXA |
||
SPXA transactions
| Type Date |
Target |
|
Private Placement
October 8, 2009 |
-- |
More Recent News About SpectrumDNA, Inc.
More news for SPXA
SPECTRUMDNA, INC. Files SEC form 10-Q, Quarterly Report
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations. The following information should be read in conjunction with the consolidated financial statements of SpectrumDNA, Inc. and the notes thereto appearing elsewhere in this report. Statements in this Management's Discussion and Analysis of Financial Condition and Results of Operations and elsewhere in this report that are not statements of historical or current fact constitute "forward looking statements". Our business and results of operations are affected by a wide variety of factors which could materially and adversely affect us and our actual results. As a result of these factors, we may experience material fluctuations in future operating results on a quarterly or annual basis, which could materially and adversely affect our business, financial condition, operating results and stock price. Projections and Forward-Looking Statements When used in this report, the words "may," "will," "expect," "anticipate," "continue," "estimate," "intend," "plans", and similar expressions are intended to identify forward-looking statements. Given the early stage of SpectrumDNA, Inc., most of the statements made herein are forward-looking. Such statements are not guarantees of future performance and are subject to risks and uncertainties and actual results may differ materially from those included within the forward-looking statements as a result of various factors. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. We undertake no obligation to publicly release the result of any revision of these forward-looking statements to reflect events or circumstances after the date they are made or to reflect the occurrence of unanticipated events. Business. (a) Organizational History SpectrumDNA, Inc....Click here to read the whole Article (external link)
SPECTRUMDNA, INC. Financials
Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback Quotes delayed, except where indicated otherwise.Delay times are 15 mins for NASDAQ, 20 mins for NYSE and Amex. See also delay times for other exchanges.Fundamental company data provided by Capital IQ. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. Quotes are updated automatically, but will be turned off after 25 minutes of inactivity. Quotes are delayed at least 15 minutes. Real-...Click here to read the whole Article (external link)
SPECTRUMDNA, INC. Files SEC form 10-Q, Quarterly Report
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations. The following information should be read in conjunction with the consolidated financial statements of SpectrumDNA, Inc. and the notes thereto appearing elsewhere in this report. Statements in this Management's Discussion and Analysis of Financial Condition and Results of Operations and elsewhere in this report that are not statements of historical or current fact constitute "forward looking statements". Our business and results of operations are affected by a wide variety of factors which could materially and adversely affect us and our actual results. As a result of these factors, we may experience material fluctuations in future operating results on a quarterly or annual basis, which could materially and adversely affect our business, financial condition, operating results and stock price. Projections and Forward-Looking Statements When used in this report, the words "may," "will," "expect," "anticipate," "continue," "estimate," "intend," "plans", and similar expressions are intended to identify forward-looking statements. Given the early stage of SpectrumDNA, Inc., most of the statements made herein are forward-looking. Such statements are not guarantees of future performance and are subject to risks and uncertainties and actual results may differ materially from those included within the forward-looking statements as a result of various factors. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. We undertake no obligation to publicly release the result of any revision of these forward-looking statements to reflect events or circumstances after the date they are made or to reflect the occurrence of unanticipated events. Business. (a) Organizational History SpectrumDNA, I...Click here to read the whole Article (external link)
SPECTRUMDNA, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Other Events
Show all filings for SPECTRUMDNA, INC. | Request a Trial to NEW EDGAR Online Pro Form 8-K for SPECTRUMDNA, INC. 6-Aug-2009Unregistered Sale of Equity Securities, Other Events Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational ...Click here to read the whole Article (external link)
SPECTRUMDNA, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (b) On June 22, 2009, James C. Ackerly submitted to the Board of Directors of SpectrumDNA, Inc. (the "Company"), and the Company accepted, Mr. Ackerly's resignation from the Board of Directors effective immediately. (d) On June 23, 2009, the Board of Directors appointed Jeff Nolan to serve as a member of the Company's Board of Directors, effective June 23, 2009. Mr. Nolan was paid a nominal fee for certain consulting services provided to the Company from May 28, 2009 to June 5, 2009. On June 6, 2009, the Company entered into a consulting agreement with Mr. Nolan pursuant to which he will provide consulting services to the Company in relation to the operations of the Company, its strategic planning, marketing, advertising and business development, and such other areas as the parties may agree from time to time. Such services will be rendered only at a time, in a manner and at a place mutually agreed upon and on a best efforts basis and may be terminated by either party at any time on prior notice. As and for the entire compensation to be paid to Mr. Nolan for any and all services to be rendered to the Company pursuant to the consulting agreement, Mr. Nolan was granted a nonstatutory stock option under the Company's 2008 Equity Incentive Plan (the "2008 Plan") to purchase 250,000 shares of the Company's Common Stock at an exercise price of $0.34 per share, subject to certain vesting conditions as set forth in such option. Mr. Nolan has also been granted a nonstatutory stock option under the Plan in conjunction with his appointment to the Board to purchase 200,000 shares of the Company's Common Stock at an exercise price of $0.33 per share, subject to certain vesting conditions as set forth in such option. Other than as disclosed in this Current Report on Form 8-K, there are no arra...Click here to read the whole Article (external link)
SPECTRUMDNA, INC. Files SEC form 10-Q, Quarterly Report
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations. The following information should be read in conjunction with the consolidated financial statements of SpectrumDNA, Inc. and the notes thereto appearing elsewhere in this report. Statements in this Management's Discussion and Analysis of Financial Condition and Results of Operations and elsewhere in this report that are not statements of historical or current fact constitute "forward looking statements". Our business and results of operations are affected by a wide variety of factors which could materially and adversely affect us and our actual results. As a result of these factors, we may experience material fluctuations in future operating results on a quarterly or annual basis, which could materially and adversely affect our business, financial condition, operating results and stock price. Projections and Forward-Looking Statements When used in this report, the words "may," "will," "expect," "anticipate," "continue," "estimate," "intend," "plans", and similar expressions are intended to identify forward-looking statements. Given the early stage of SpectrumDNA, Inc., most of the statements made herein are forward-looking. Such statements are not guarantees of future performance and are subject to risks and uncertainties and actual results may differ materially from those included within the forward-looking statements as a result of various factors. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. We undertake no obligation to publicly release the result of any revision of these forward-looking statements to reflect events or circumstances after the date they are made or to reflect the occurrence of unanticipated events. Business. (a) Organizational History SpectrumDNA, Inc. was in...Click here to read the whole Article (external link)
SPECTRUMDNA, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Show all filings for SPECTRUMDNA, INC. | Request a Trial to NEW EDGAR Online Pro Form 8-K for SPECTRUMDNA, INC. 17-Apr-2009Change in Directors or Principal Officers Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, ...Click here to read the whole Article (external link)
SPECTRUMDNA, INC. Files SEC form 10-K, Annual Report
ITEM 7. Management's Discussion and Analysis of Financial Condition and Results of Operations This discussion summarizes the significant factors affecting the operating results, financial condition, liquidity and cash flows of the Company and its subsidiary for the fiscal years ended December 31, 2008 and 2007. The discussion and analysis that follows should be read together with the consolidated financial statements of SpectrumDNA, Inc. and the notes to the consolidated financial statements included elsewhere in this annual report on Form 10-K. Except for historical information, the matters discussed in this section are forward looking statements that involve risks and uncertainties and are based upon judgments concerning various factors that are beyond the Company's control. Application of Critical Accounting Policies and Estimates Our consolidated financial statements and accompanying notes are prepared in accordance with generally accepted accounting principles in the United States. Preparing financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses. These estimates and assumptions are affected by management's application of accounting policies. Critical accounting policies for us include our accounting for inventory reserves, intangible assets, and share based payment arrangements. Intangible Assets Intangible assets for us are patents, trademarks and other rights. Statement of Financial Accounting Standards (SFAS) No. 142, Goodwill and Other Intangible Assets, requires that goodwill and other intangible assets be tested for impairment on an annual basis and between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value. These events or circumstances could include a significant change in the business climate, legal factors, operating per...Click here to read the whole Article (external link)
SPECTRUMDNA, INC. Files SEC form 8-K, Other Events
Show all filings for SPECTRUMDNA, INC. | Request a Trial to NEW EDGAR Online Pro Form 8-K for SPECTRUMDNA, INC. 13-Mar-2009Other Events Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purp...Click here to read the whole Article (external link)
SPECTRUMDNA, INC. Files SEC form 10-Q, Quarterly Report
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations. The following information should be read in conjunction with the consolidated financial statements of SpectrumDNA, Inc. and the notes thereto appearing elsewhere in this report. Statements in this Management's Discussion and Analysis of Financial Condition and Results of Operations and elsewhere in this report that are not statements of historical or current fact constitute "forward looking statements". Our business and results of operations are affected by a wide variety of factors which could materially and adversely affect us and our actual results. As a result of these factors, we may experience material fluctuations in future operating results on a quarterly or annual basis, which could materially and adversely affect our business, financial condition, operating results and stock price. Projections and Forward-Looking Statements When used in this report, the words "may," "will," "expect," "anticipate," "continue," "estimate," "intend," "plans", and similar expressions are intended to identify forward-looking statements. Given the early stage of SpectrumDNA, Inc., most of the statements made herein are forward-looking. Such statements are not guarantees of future performance and are subject to risks and uncertainties and actual results may differ materially from those included within the forward-looking statements as a result of various factors. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. We undertake no obligation to publicly release the result of any revision of these forward-looking statements to reflect events or circumstances after the date they are made or to reflect the occurrence of unanticipated events. Overview SpectrumDNA, Inc. (www.spectrumdna.com) was incorporated under the...Click here to read the whole Article (external link)
